Skip to main content
Clinical Trials/NCT02660931
NCT02660931
Completed
Not Applicable

Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research

Vanderbilt University Medical Center1 site in 1 country12,108 target enrollmentNovember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Acute Kidney Injury
Sponsor
Vanderbilt University Medical Center
Enrollment
12108
Locations
1
Primary Endpoint
Number of Serum Creatinine Tests Ordered
Status
Completed
Last Updated
7 years ago

Overview

Brief Summary

This proposal will incorporate statistical models developed by the investigators to predict risk for acute kidney injury into our electronic medical record system, enabling an alert to notify providers of the risk status. Pediatric inpatients will be randomly assigned to be in the intervention group, for whom the notification will be implemented, or in the control group, who will receive usual care (no notification). The investigators believe the notification will increase appropriate screening for acute kidney injury and reduce the severity of acute kidney injury in the intervention group.

Detailed Description

This proposal will incorporate a logistic regression models developed by the investigators to predict risk for acute kidney injury in pediatric intensive care unit and pediatric ward patients into the electronic medical record system, enabling personalized decision support. Real-time surveillance using the risk prediction models will identify pediatric inpatients at increased risk for acute kidney injury. When patients exceed the threshold risk for acute kidney injury, the electronic medical record system will notify providers. Patients will be randomly assigned to be in the intervention group, for whom the notification will be implemented, or in the control group, for whom the notification will not display. The risk notification will be assessed for its impact on outcomes including rates of screening for acute kidney injury and the severity of acute kidney injury.

Registry
clinicaltrials.gov
Start Date
November 2016
End Date
November 2018
Last Updated
7 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sara Van Driest

Assistant Professor

Vanderbilt University Medical Center

Eligibility Criteria

Inclusion Criteria

  • All admissions to the pediatric intensive care unit or pediatric wards at the Monroe Carell Junior Children's Hospital at Vanderbilt

Exclusion Criteria

  • Prior diagnosis of chronic renal disease, including dialysis and transplant
  • Admission to the Neonatal Intensive Care Unit during the current admission

Outcomes

Primary Outcomes

Number of Serum Creatinine Tests Ordered

Time Frame: Admission through Discharge (approximately 2 days to 1 week)

Measure of efficacy of the clinical decision support to lead to increased screening for acute kidney injury.

Secondary Outcomes

  • Renal Replacement Therapy (number requiring RRT)(Admission through Discharge (approximately 2 days to 1 week))
  • Length of Stay (days)(Admission through Discharge (approximately 2 days to 1 week))
  • Acute Kidney Injury Severity (as measured by Kidney Disease Improving Global Outcomes [KDIGO] stage 1, 2 or 3)(Admission through Discharge (approximately 2 days to 1 week))
  • In-hospital Mortality(Admission through Discharge (approximately 2 days to 1 week))

Study Sites (1)

Loading locations...

Similar Trials